Review of Ophthalmology Online

FROM THE EDITORS OF REVIEW OF OPHTHALMOLOGY:







#########
Volume 18, Number 39
Monday, September 24, 2018
#########


SEPTEMBER IS HEALTHY AGING MONTH



In this issue: (click heading to view article)
#########
######### SS-OCT Facedown Position Post-vitrectomy & Macular Hole Closures
#########
######### RPE Hyperplasia Overlying PED in AMD Can Masquerade as Neovascularization on OCTA
#########
######### Evaluating Anterior Chamber Volume After Cataract Surgery With SS-OCT
#########
######### OCTA Retinal Flow Density for Detection of Nonperfused Areas in DR
#########
  Briefly

 

SS-OCT Facedown Position Post-vitrectomy & Macular Hole Closures

Researchers compared clinical outcomes in eyes with macular hole managed by either facedown (FD) or no-FD (nFD) postoperative positioning protocols, as part of a prospective, randomized cohort study.

Eighty eyes of 80 consecutive individuals with MH that underwent vitrectomy surgery with internal limiting membrane peeling and gas tamponade were included. Forty eyes of 40 individuals kept in FD position for three days after surgery were assigned to the FD group, and 40 eyes of 40 individuals with nFD positioning were assigned to the nFD group. Researchers examined macular holes with swept-source optical coherence tomography images at one day, two days, three days, two weeks, one month and three months after surgery. They compared the MH closure rate and change of best-corrected visual acuity. Below are some of the findings:

• At postoperative day one, MHs were closed in 24 of 32 eyes (with clear OCT images) (75 percent) in the FD group, and 23 of 30 eyes (with clear OCT images) (77 percent) in the nFD group (p=0.97).
• At postoperative day two, MH closures were confirmed in 32 of 36 eyes (88.9 percent) in the FD group and in 31 of 33 eyes (94 percent) in the nFD group (p=0.84); results were unchanged at day three.
• At two weeks post-surgery, clear OCT images were acquired from all eyes in both groups, and MH closures were confirmed in 36 of 40 eyes (90 percent) in the FD group and in 37 of 40 (92.5 percent) eyes in the nFD group (p=0.91).
• Macular hole closures weren’t achieved in eyes kept open by day three post-surgery, and no eyes with confirmed MH closures by day three had reopenings by three months.
• The distribution of macular configurations at three months wasn’t significantly different between the two groups (p=0.96).
• Researchers found no differences in improvement in best-corrected visual acuity (Early Treatment Diabetic Retinopathy Study letters gain) between the two groups at one month (p=0.22) and three months (p=0.45).

Researchers found that the nFD protocol neither delayed MH closures nor decreased the final closure rate after vitrectomy surgery. As such, they suggested that using the prone position postoperatively seemed to be unnecessary for all MH repair procedures.

SOURCE: Zhang Y, Chen X, Hong L, et al. Facedown positioning after vitrectomy will not facilitate macular hole closure based on swept-source optical coherence tomography imaging in gas-filled eyes: A prospective, randomized comparative interventional study. Retina 2018; Sep 7. [Epub ahead of print].





RPE Hyperplasia Overlying PED in AMD Can Masquerade as Neovascularization on OCTA

Investigators reported image artifacts due to retinal pigment epithelium hyperplasia overlying retinal pigment epithelial detachment in age-related macular degeneration, which can masquerade as neovascularization on optical coherence tomography angiography.

The hospital-based, retrospective and cross-sectional study included 22 eyes from 16 subjects with non-vascularized PED related to AMD. All subjects were examined by OCTA, spectral-domain OCT, fluorescein angiography and indocyanine green angiography. Investigators evaluated vascular flow signals on the outer retinal slab of en face OCTA and cross-sectional OCTA images, and their correspondence with RPE hyperplasia. Here are some of the investigators’ findings:

• Fifteen eyes (68.2 percent) showed VFS on both the outer retina slab of en face OCTA and cross-sectional OCTA, all corresponding with RPE hyperplasia overlying PED. Among them, 12 eyes with lump RPE hyperplasia outside the foveal avascular zone showed obvious VFS on the outer retina slab of OCTA, and three eyes with scattered RPE hyperplasia outside the FAZ showed VFS fragments.
• Four eyes had accompanied RPE hyperplasia inside the FAZ, and seven eyes without RPE hyperplasia overlying PED showed no corresponding VFS on the outer retina slab of OCTA.
• Investigators observed round, dark bands at the edge of PED in the outer retina slab on en face OCTA in 17 eyes (77.3 percent).

Investigators determined that RPE hyperplasia overlying PED in AMD could masquerade as neovascularization on OCTA. They suggested that this RPE hyperplasia-related image artifact should be considered when interpreting OCTA images to avoid misdiagnosis and unnecessary treatment.

SOURCE: Chen L, Zhang X, Yuhong Gan Y, et al. Retinal pigment epithelium hyperplasia overlying pigment epithelial detachment in age-related macular degeneration can masquerade as neovascularization on optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol 2018; Sept. 18. [Epub ahead of print].



Evaluating Anterior Chamber Volume Post-Cataract Surgery With SS-OCT

Scientists assessed changes in anterior chamber volume with swept-source optical coherence tomography after cataract surgery in addition to factors that influenced the ACV changes, as part of a prospective cohort study.

Fifty-one individuals who underwent cataract surgery were enrolled. Their ACV, anterior chamber depth and angle widths were measured with SS-OCT before, and one day, one week and one month after surgery. Scientists looked for associations between changes in ACV and posterior vitreous detachments, and determined axial lengths. Here are some of their findings:

• Compared with preoperative volumes, ACV increased significantly at all three postoperative time points (all p<0.001).
• ACV was greater at one week than one day after surgery (p<0.001).
• AXL and PVDs were significantly associated with ACV changes one day post-surgery (p=0.005).
• Neither PVDs nor AXL affected ACV changes between one day and one week after surgery.
• ACV stabilized in the first week after cataract surgery.

Scientists reported that absorption of irrigation fluid and balanced salt solution in the vitreous cavity contributed to ACV changes one week after surgery. Eyes with longer AXL and PVD tended to show less ACV changes one day after surgery.

SOURCE: Chen M, Hu H, He W, et al. Observation of anterior chamber volume after cataract surgery with swept-source optical coherence tomography. Int Ophthalmol 2018; Sep 4. [Epub ahead of print].




OCTA Retinal Flow Density for Detection of Nonperfused Areas in DR

Researchers wrote that fluorescein angiography has been used for qualitative detection of retinal nonperfused area in diabetic retinopathy. Recently, they added, optical coherence tomography angiography reportedly has been useful for the quantification of retinal vascular disorders in DR. Researchers assessed whether retinal flow density measurements by OCTA were useful for NPA detection in DR.

The study included 41 eyes from 29 individuals with DR that underwent FA and OCTA. Regions surrounded by arteries or veins were extracted in OCTA images, and FDs were measured by Image J. Researchers classified each region as NPAs or perfused areas in FA. They prepared ROC curves by logistic regression analysis of the FDs, and calculated AUC and FD cutoff values. Researchers analyzed 252 regions and classified them into 38 NPA and 214 PA regions using FA. Here are some of their findings:

• The FD of each capillary plexus in NPAs was significantly smaller than in PA (p<0.0001).
• The AUC was: 0.975 for total capillary plexus (TCP) layers; 0.974 for superficial capillary plexus layers; and 0.971 for deep capillary plexus layers.
• All areas where the FD was more than the cutoff value (0.07 in TCP) were diagnosed as PAs.
• Three areas with intraretinal microvascular abnormalities were diagnosed as PAs despite being below the cutoff value.

Researchers concluded that FD measurements in OCTA were useful for NPA detection in DR.

SOURCE: Kaizu Y, Nakao S, Sekiryu H, et al. Retinal flow density by optical coherence tomography angiography is useful for detection of nonperfused areas in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2018; Sep 6. [Epub ahead of print].






  • Heidelberg OCTA Module Available in United States
    Heidelberg Engineering, a privately-held imaging solutions company focused on advanced diagnostic instruments and IT solutions for eye care professionals, announced that it received U.S. FDA clearance for its OCT Angiography Module. The additional module is now available for new and existing Spectralis upgradeable diagnostic imaging devices. Read more.


  • Quantel Releases ABSolu Ultrasound
    Quantel Medical released its new ultrasound device, the ABSolu, at this year’s Congress of the European Society of Cataract and Refractive Surgeons in Vienna. The company says ABSolu uses a five-ring annular technology 20 MHz B probe that increases depth of field by 70 percent, motion sensors that automatically detect the probe position, new signal processing and a full HD screen. Read more.


  • Alcon Launches Alcon Experience Academy
    Alcon is expanding its global support of eye-care professionals through the unveiling of the Alcon Experience Academy. The program offers face-to-face training and online educational resources by leading specialists from around the world to provide the best patient care, the company says. As part of this effort, Alcon is launching a new online portal, AlconExperienceAcademy.com, which will house a growing library of educational materials for eye-care providers. The website includes a library of more than 500 training videos, with additional content added regularly, as well as webcasts developed by leading eye-care specialists from around the world, and personalized videos and curricula across several disease states and focus areas. The materials primarily focus on real-world surgical case studies using the latest innovations in eye care. Resources specific to optometry are due to be released early next year. Read more.

  • Sun Pharmaceutical & SPARC Get FDA Nod for Xelpros to Treat OAG or OH
    Sun Pharmaceutical Industries announced U.S. FDA approval for the New Drug Application of Xelpros (latanoprost ophthalmic emulsion) 0.005% for the reduction of elevated intraocular pressure in individuals with open-angle glaucoma or ocular hypertension. (Sun Pharmaceutical in-licensed Xelpros from SPARC in June 2015.) Xelpros—the first and only form of latanoprost that isn’t formulated with benzalkonium chloride—was developed using SPARC’s proprietary swollen micelle microemulsion technology. In randomized, controlled clinical trials of individuals with OAG or OH with a mean baseline IOP of 23 to 26 mmHg, Xelpros lowered IOP by a mean of up to 6 to 8 mmHg. Read more.

  • Iridex Announces MicroPulse Treatment Symposium at ESCRS
    Iridex will be hosting a symposium at the Annual Meeting of the European Society for Cataract and Refractive Surgeons in Vienna, Austria, on Sept. 22. The program, MicroPulse Technology: Latest Trends in Laser Treatment Choices for Glaucoma and Retinal Diseases, will feature five world-renowned glaucoma and retina specialists who plan to share how they are using the company’s technology. The one-hour session will feature multiple cases and results, and include time for audience questions. Learn more.

  • ASCRS Convenes Independent Panel to Review COMPASS-XT Study Data
    The American Society of Cataract and Refractive Surgery formed a task force to review data from the COMPASS-XT study and associated research, and develop a physician guidance document associated with the voluntary withdrawal of Alcon’s CyPass Micro-Stent. The task force, composed of ASCRS Clinical Committee leaders specializing in glaucoma and cornea, will conduct an independent evaluation of the data and release an objective summation of its findings, as well as provide preliminary clinical recommendations for managing individuals with indwelling CyPass devices. The document is expected to be released shortly. Alcon announced the voluntary withdrawal of the CyPass Micro-Stent from the global market in August 29.

  • Katena Launches New Website
    Katena Products updated its website to increase interactivity, ecommerce, engagement and education. The new site enables existing and prospective customers to review Katena products and order online. It integrates all Katena instrument, Barron corneal device, Katena/IOP biologics, lens and EagleVision punctum plug lines into a fully searchable site. Visit the website.



Review of Ophthalmology® Online is published by the Review Group, a Division of Jobson Medical Information LLC (JMI), 11 Campus Boulevard, Newtown Square, PA 19073.

To subscribe to other JMI newsletters or to manage your subscription, click here.

To change your email address, reply to this email. Write "change of address" in the subject line. Make sure to provide us with your old and new address.

To ensure delivery, please be sure to add reviewophth@jobsonmail.com to your address book or safe senders list.

Click here if you do not want to receive future emails from Review of Ophthalmology Online.

Advertising: For information on advertising in this e-mail newsletter or other creative advertising opportunities with Review of Ophthalmology, please contact sales managers James Henne or Michele Barrett.

News: To submit news or contact the editor, send an e-mail, or FAX your news to 610.492.1049